Correlation Between 4D Molecular and UroGen Pharma
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and UroGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and UroGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and UroGen Pharma, you can compare the effects of market volatilities on 4D Molecular and UroGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of UroGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and UroGen Pharma.
Diversification Opportunities for 4D Molecular and UroGen Pharma
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between FDMT and UroGen is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and UroGen Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UroGen Pharma and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with UroGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UroGen Pharma has no effect on the direction of 4D Molecular i.e., 4D Molecular and UroGen Pharma go up and down completely randomly.
Pair Corralation between 4D Molecular and UroGen Pharma
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the UroGen Pharma. In addition to that, 4D Molecular is 1.14 times more volatile than UroGen Pharma. It trades about -0.03 of its total potential returns per unit of risk. UroGen Pharma is currently generating about 0.06 per unit of volatility. If you would invest 1,225 in UroGen Pharma on August 30, 2024 and sell it today you would earn a total of 41.00 from holding UroGen Pharma or generate 3.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. UroGen Pharma
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| UroGen Pharma |
4D Molecular and UroGen Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and UroGen Pharma
The main advantage of trading using opposite 4D Molecular and UroGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, UroGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UroGen Pharma will offset losses from the drop in UroGen Pharma's long position.| 4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
| UroGen Pharma vs. Eliem Therapeutics | UroGen Pharma vs. Inhibrx | UroGen Pharma vs. Celcuity LLC | UroGen Pharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |